XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance, beginning of period at Dec. 31, 2022 $ 11 $ 440,880 $ (54,568) $ (3,533) $ 382,790
Balance, beginning of period (in shares) at Dec. 31, 2022 114,667,975        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (14,368)   (14,368)
Foreign currency translation adjustments       (144) (144)
Issuance of common stock upon release of restricted stock units (in shares) 22,078        
Stock-based compensation expense   6,769     6,769
Balance, end of period at Apr. 01, 2023 $ 11 447,649 (68,936) (3,677) 375,047
Balance, end of period (in shares) at Apr. 01, 2023 114,690,053        
Balance, beginning of period at Dec. 31, 2022 $ 11 440,880 (54,568) (3,533) 382,790
Balance, beginning of period (in shares) at Dec. 31, 2022 114,667,975        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (8,653)
Balance, end of period at Jul. 01, 2023 $ 11 453,413 (63,221) (4,006) 386,197
Balance, end of period (in shares) at Jul. 01, 2023 114,734,756        
Balance, beginning of period at Apr. 01, 2023 $ 11 447,649 (68,936) (3,677) 375,047
Balance, beginning of period (in shares) at Apr. 01, 2023 114,690,053        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     5,715   5,715
Foreign currency translation adjustments       (329) (329)
Issuance of common stock upon release of restricted stock units (in shares) 98,974        
Stock-based compensation expense   5,764     5,764
Balance, end of period at Jul. 01, 2023 $ 11 453,413 (63,221) (4,006) 386,197
Balance, end of period (in shares) at Jul. 01, 2023 114,734,756        
Balance, beginning of period at Dec. 31, 2023 $ 11 459,684 (56,956) (3,539) 399,200
Balance, beginning of period (in shares) at Dec. 31, 2023 114,871,782        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (7,864)   (7,864)
Foreign currency translation adjustments       (811) (811)
Issuance of common stock upon release of restricted stock units (in shares) 517,907        
Stock-based compensation expense   1,243     1,243
Balance, end of period at Mar. 30, 2024 $ 11 460,927 (64,820) (4,350) 391,768
Balance, end of period (in shares) at Mar. 30, 2024 115,389,689        
Balance, beginning of period at Dec. 31, 2023 $ 11 459,684 (56,956) (3,539) 399,200
Balance, beginning of period (in shares) at Dec. 31, 2023 114,871,782        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         5,415
Balance, end of period at Jun. 29, 2024 $ 12 463,027 (51,541) (3,367) 408,131
Balance, end of period (in shares) at Jun. 29, 2024 115,577,103        
Balance, beginning of period at Mar. 30, 2024 $ 11 460,927 (64,820) (4,350) 391,768
Balance, beginning of period (in shares) at Mar. 30, 2024 115,389,689        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     13,279   13,279
Foreign currency translation adjustments       983 983
Issuance of common stock upon release of restricted stock units $ 1       1
Issuance of common stock upon release of restricted stock units (in shares) 187,414        
Stock-based compensation expense   2,100     2,100
Balance, end of period at Jun. 29, 2024 $ 12 $ 463,027 $ (51,541) $ (3,367) $ 408,131
Balance, end of period (in shares) at Jun. 29, 2024 115,577,103